An Optimized Lentiviral Vector Efficiently Corrects the Human Sickle Cell Disease Phenotype
Autologous transplantation of hematopoietic stem cells transduced with a lentiviral vector (LV) expressing an anti-sickling HBB variant is a potential treatment for sickle cell disease (SCD). With a clinical trial as our ultimate goal, we generated LV constructs containing an anti-sickling HBB trans...
Main Authors: | Leslie Weber, Valentina Poletti, Elisa Magrin, Chiara Antoniani, Samia Martin, Charles Bayard, Hanem Sadek, Tristan Felix, Vasco Meneghini, Michael N. Antoniou, Wassim El-Nemer, Fulvio Mavilio, Marina Cavazzana, Isabelle Andre-Schmutz, Annarita Miccio |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-09-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050118300767 |
Similar Items
-
Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases
by: Valentina Poletti, et al.
Published: (2021-08-01) -
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease
by: Valentina Poletti, et al.
Published: (2018-12-01) -
GATA Factor-Mediated Gene Regulation in Human Erythropoiesis
by: Oriana Romano, et al.
Published: (2020-04-01) -
Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID
by: Sabine Charrier, et al.
Published: (2019-12-01) -
The GATA1-HS2 enhancer allows persistent and position-independent expression of a β-globin transgene.
by: Annarita Miccio, et al.
Published: (2011-01-01)